Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia-Reference-Cited by-同舟云学术

Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia

Published:2021-02-10 Issue: Volume: Page:1-2
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Aksan Aysegül¹²³^ORCID,Dignass Axel⁴^ORCID,Stein Jürgen¹³⁵^ORCID

Affiliation:

1. Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt Am Main, Germany

2. Institute of Nutritional Science, Justus-Liebig University, Gießen, Germany

3. Interdisciplinary Crohn Colitis Center Rhein-Main, Frankfurt Am Main, Germany

4. Department of Medicine I, Agaplesion Markus Hospital, Frankfurt Am Main, Germany

5. Gastroenterology and Clinical Nutrition, DGD Clinics Sachsenhausen, Frankfurt Am Main, Germany

Funder

not funded

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1883948

Reference12 articles.

1. Pharmacosmos A/S. Iron isomaltoside and iron sucrose for the treatment of iron deficiency anemia in non-dialysis-dependent chronic kidney disease. NCT02940860. [cited 2019 Oct 1]. Available from: https://clinicaltrials.gov/ct2/show/NCT02940860.

2. Pharmacosmos A/S. An extension trial to assess the safety of redosing of iron isomaltoside (Monofer®) (FerWonExt). October 1, 2019 [cited 2019 Sept 5]. Available from: https://clinicaltrials.gov/ct2/show/NCT02962648.

3. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

4. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: A multi-centred, placebo-controlled preliminary clinical trial